ARMnet is a global iPaaS software provider offering cloud based solutions to clients in the financial services sector. The ARMnet Platform is an innovative cloud-based integration and processing software platform as a service – known in the industry as an iPaaS. The ARMnet Platform is used by large corporate clients in the insurance, non-bank mortgage lending and funds management sectors.
Little Green Pharma Ltd operates in the medicinal cannabis industry. Together with its exclusive Manufacturing Partner and via its distribution arrangements, Little Green Pharma operates a vertically integrated medicinal cannabis business comprising cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company aims to take advantage of opportunities relating to the emerging medicinal cannabis industry in Australia and in certain international jurisdictions.
Kaiser Reef Limited is an Australian unlisted public company, which was incorporated on 2 September 2019 for the purpose of completing the Acquisition and being admitted to the Official List of the ASX. The Company has entered into the Acquisition Agreement with Chase Metals Pty Ltd (Chase Metals) pursuant to which the Company has agreed, subject to satisfaction of certain conditions precedent, to acquire all of the Chase Shares from the Chase Shareholders. Chase Metals is the beneficial owner of one exploration licence (EL 8491) and one exploration licence application (ELA 5854) located in New South Wales.
thedocyard Limited is globally recognised as a leading end-to-end transaction management solution and is on a mission to becoming a leading provider of deal technology to the world’s legal and financial services sectors. thedocyard is a cloud-based deal space built specifically for managing the entire lifecycle of any corporate or commercial transaction. Geographically, thedocyard is predominantly sold in the Australian market and is now growing in the UK market. The Asian and North American deals markets will follow those.
Emerald Clinics Limited (ACN 625 085 734) is an Australian incorporated company that operates a network of specialist medical clinics and uses purposebuilt software and technology to gather high quality clinical data from informed and consenting patients. Emerald is a clinical services and healthcare technology company focussed on the provision of care for patients clinically determined to have exhausted conventional therapies and who may be suitable for cannabinoid-based medicines. In addition, Emerald uses technology to capture clinical data that can be used to generate clinical evidence relating to the safety and efficacy of cannabinoidbased medicines.
COSOL is a global, professional service provider, specializing in providing strategic advice and practical delivery to optimize our clients’ business processes and technology systems. The specialists have a valuable combination of asset-intensive industry experience and technology systems expertise. This combination enables COSOL to strategically plan, design, deliver and optimize operational systems and enterprise systems, continually optimize business processes and efficiently solve the most complex issues.
Cobre Limited was incorporated for the purpose of identifying, evaluating and pursuing various exploration and/or mining opportunities in the resources sector and to ultimately list on ASX. The Company’s strategy is to focus on minerals and metals where the market outlook indicates potential supply shortages. The Board views base metals generally, and copper specifically, as being aligned with this strategy.
Limeade is a leading provider of cloud-based employee experience software solutions. Limeade has over 230 employees and is headquartered in Bellevue, Washington State, US, with offices in Canada and Germany. Limeade has 176 organizations as customers (as at 30 September 2019), with over 2.4 million users located in the US and approximately 100 other countries. Through its software solutions, Limeade helps organizations better care for their employees.
Nyrada Inc. is a pre-clinical drug development company specialising in the development of novel small molecule drugs pertaining to cardiovascular, neurological and chronic inflammatory diseases. The Company’s vision is to become a high growth, bio-pharmaceutical company specialising in drug discovery and early stage drug development in areas of substantial unmet market need, where few, if any, effective or well-tolerated therapies exist.